Author:
Charton E.,Falcoz A.,François E.,Touraine C.,Bachet J.-B.,Louvet C.,Hamidou Z.,Bascoul-Mollevi C.,Anota A.
Funder
Institut National Du Cancer
Subject
Health Informatics,Computer Science Applications,Software
Reference21 articles.
1. Health-related quality of life and cancer clinical trials;Osoba;Ther. Adv. Med. Oncol.,2011
2. Patient-reported outcomes as end points and outcome indicators in solid tumours;Secord;Nat. Rev. Clin. Oncol.,2015
3. Quality-of-life end points in cancer clinical trials: the U.S. food and drug administration perspective;Beitz;J. Natl. Cancer Inst. Monogr.,1996
4. FDA, Clinical trial endpoints for the approval of cancer drugs and biologics guidance for industry, (2007).
5. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance;Health Qual. Life Outcomes,2006